Join
Login
Join
Login
"Where Everyone Has an MBA"
Tel: (612) 246-4616
Home
Financial Analysis
Companies
Industries
Glossary
About
Frequently Asked Questions
User Testimonials
Contact Us
Navigation
Home
Financial Analysis
Companies
Industries
Glossary
About
- Frequently Asked Questions
- User Testimonials
Contact Us
AngioDynamics, Inc. - SIC # 3840 -
Ticker
Exchange
SIC #
Website
Latest Ticker
ANGO
Nasdaq
3840
www.angiodynamics.com
Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:
Latest Headlines for AngioDynamics, Inc.
Bastion Bets on Government Spending with $8 Million New Stake in Parsons
- Feb 27th, 2026 1:57 pm
TMDX Stock Rises as Q4 Earnings & Revenues Beat Estimates
- Feb 25th, 2026 9:50 am
AngioDynamics to Present at the Leerink Partners Global Healthcare Conference
- Feb 23rd, 2026 2:30 pm
AngioDynamics Expands Indications for the NanoKnife System Across Europe, Strengthening Multi-Organ Tumor Ablation Platform
- Feb 19th, 2026 6:30 am
DexCom Stock Falls Despite Q4 Earnings Beat, G7 Rollout Drives Growth
- Feb 13th, 2026 10:35 am
Does AngioDynamics (ANGO) Have the Potential to Rally 92.15% as Wall Street Analysts Expect?
- Feb 6th, 2026 7:55 am
AngioDynamics (ANGO) Down 3.9% Since Last Earnings Report: Can It Rebound?
- Feb 5th, 2026 9:30 am
AngioDynamics and The PERT Consortium® Launch Investigator-Led Research Fund to Advance Pulmonary Embolism Care
- Feb 5th, 2026 6:00 am
Here's Why You Should Add Masimo Stock to Your Portfolio Now
- Feb 4th, 2026 10:51 am
AngioDynamics to Convene Cardiovascular Leaders at Scientific Forum as Pipeline Continues to Advance
- Feb 3rd, 2026 6:00 am
Here's Why AngioDynamics (ANGO) Is a Great 'Buy the Bottom' Stock Now
- Jan 30th, 2026 7:55 am
Reasons to Add AngioDynamics Stock to Your Portfolio for Now
- Jan 29th, 2026 10:47 am
AngioDynamics J.P. Morgan Conference: MedTech Growth Push, Cash-Flow Path, CEO Retirement Plan
- Jan 14th, 2026 5:04 pm
The Zacks Analyst Blog Highlights AngioDynamics, Boston Scientific and Medtronic
- Jan 14th, 2026 8:13 am
Down 25.0% in 4 Weeks, Here's Why You Should You Buy the Dip in AngioDynamics (ANGO)
- Jan 12th, 2026 7:35 am
Is AngioDynamics' (ANGO) Higher Sales Guidance Enough To Offset CEO Transition Concerns?
- Jan 8th, 2026 8:13 pm
ANGO Stock Dips Despite Q2 Earnings Beat, Gross Margin Improves
- Jan 7th, 2026 10:11 am
AngioDynamics Inc (ANGO) Q2 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic ...
- Jan 6th, 2026 12:00 pm
AngioDynamics (ANGO) Q1 2026 Earnings Transcript
- Jan 6th, 2026 10:45 am
AngioDynamics (ANGO) Q3 2025 Earnings Transcript
- Jan 6th, 2026 10:42 am
Scroll